Company Filing History:
Years Active: 2007
Title: Xavier De Leval: Innovator in Pyridinic Sulfonamide Derivatives
Introduction
Xavier De Leval is a notable inventor based in Louveigné, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyridinic sulfonamide derivatives.
Latest Patents
De Leval holds a patent for "Pyridinic sulfonamide derivatives method of production and use thereof." This patent describes new pyridinic sulfonamide derivatives represented by a general formula (I), wherein R1 represents a mono- or polyhalogenated C1–12-alkyl or a mono- or poly-halogenated C3–8-cycloalkyl group. The patent outlines the method of production for these derivatives and their application as active therapeutic substances in treating various diseases, including inflammation, arthrosis, cancer, angiogenesis, and asthma. He has 1 patent to his name.
Career Highlights
Xavier De Leval is affiliated with the University of Liège, where he conducts research and develops innovative solutions in the field of pharmaceuticals. His work has garnered attention for its potential impact on therapeutic treatments.
Collaborations
Throughout his career, De Leval has collaborated with esteemed colleagues such as Jacques Delarge and Bernard Pirotte. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Xavier De Leval's contributions to the field of medicinal chemistry, particularly through his work on pyridinic sulfonamide derivatives, highlight his role as an influential inventor. His research continues to pave the way for new therapeutic options in medicine.